Back to Results
First PageMeta Content
Health / Food and Drug Administration / Clinical pharmacology / Therapeutics / United States Public Health Service / KV Pharmaceutical / 17-Hydroxyprogesterone caproate / Compounding / FDA Warning Letter / Pharmacology / Pharmaceutical sciences / Clinical research


USCA Case #[removed]Document #[removed]Filed: [removed]
Add to Reading List

Document Date: 2014-12-17 12:04:58

Open Document

File Size: 126,34 KB

Share Result on Facebook
UPDATE